• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

匈牙利全科医生诊治的成年患者中未确诊的异常葡萄糖耐量的流行情况。基于 FINDRISC 问卷的风险分层筛查的结果。

Prevalence of undiagnosed abnormal glucose tolerance in adult patients cared for by general practitioners in Hungary. Results of a risk-stratified screening based on FINDRISC questionnaire.

机构信息

Department of Medicine and Diabetology, Saint John's Hospital, Budapest, Hungary.

出版信息

Med Sci Monit. 2013 Jan 24;19:67-72. doi: 10.12659/msm.883747.

DOI:10.12659/msm.883747
PMID:23344680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3629009/
Abstract

BACKGROUND

The prevalence of type 2 diabetes mellitus is rapidly increasing, worldwide and also in Hungary. Timely diagnosis and early treatment could be aided by targeted screening. Recognizing this, the Hungarian Diabetes Association initiated a risk-stratified screening with the involvement of primary care physicians.

MATERIAL/METHODS: In the first phase of screening, the FINDRISC questionnaire was completed, followed by an oral glucose tolerance test (OGTT) for those with a score of ≥12. Between September 1, 2010 and March 31, 2011, 70,432 non-diabetic adults, who visited their general practitioners for any reason, were involved in the screening. Of these, 68,476 questionnaires proved to be suitable for processing.

RESULTS

From the questionnaires, 28,077 (41.0%) had a score of ≥12. A valid OGTT was performed in 22,846 cases; of this group 3,217 subjects (14.1%) had elevated fasting glucose levels, 5,663 (24.8%) had impaired glucose tolerance, and 1,750 (7.6%) had manifest, previously undiagnosed, diabetes mellitus. Overall, from the valid OGTT group, 46.5% subjects had some degree of glucose intolerance.

CONCLUSIONS

Based on the FINDRISC questionnaire, the risk-stratified screening for diabetes mellitus proved to be simple and cost-effective method for the early detection of carbohydrate metabolism disorders. Using this method, the prevalence rate of previously undiagnosed abnormal glucose tolerance was high in adult patients cared for by general practitioners in Hungary.

摘要

背景

2 型糖尿病的患病率在全球范围内迅速上升,在匈牙利也是如此。及时诊断和早期治疗可以通过有针对性的筛查来辅助。认识到这一点,匈牙利糖尿病协会启动了一项风险分层筛查,初级保健医生参与其中。

材料/方法:在筛查的第一阶段,完成了 FINDRISC 问卷,如果得分≥12,则进行口服葡萄糖耐量试验(OGTT)。2010 年 9 月 1 日至 2011 年 3 月 31 日,共有 70432 名非糖尿病成年人因任何原因就诊于他们的全科医生,参与了筛查。在这些人中,有 68476 份问卷适合处理。

结果

从问卷中,有 28077 人(41.0%)得分≥12。在 22846 例中进行了有效的 OGTT;在这一组中,有 3217 名受试者(14.1%)空腹血糖升高,5663 名(24.8%)葡萄糖耐量受损,1750 名(7.6%)患有明显的、以前未诊断的糖尿病。总体而言,在有效的 OGTT 组中,46.5%的受试者存在某种程度的葡萄糖耐量异常。

结论

基于 FINDRISC 问卷,糖尿病的风险分层筛查被证明是一种简单且具有成本效益的方法,可早期发现碳水化合物代谢紊乱。使用这种方法,在匈牙利由全科医生照顾的成年患者中,以前未诊断的异常葡萄糖耐量的患病率较高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708a/3629009/11577d0b1fb4/medscimonit-19-67-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708a/3629009/11577d0b1fb4/medscimonit-19-67-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/708a/3629009/11577d0b1fb4/medscimonit-19-67-g001.jpg

相似文献

1
Prevalence of undiagnosed abnormal glucose tolerance in adult patients cared for by general practitioners in Hungary. Results of a risk-stratified screening based on FINDRISC questionnaire.匈牙利全科医生诊治的成年患者中未确诊的异常葡萄糖耐量的流行情况。基于 FINDRISC 问卷的风险分层筛查的结果。
Med Sci Monit. 2013 Jan 24;19:67-72. doi: 10.12659/msm.883747.
2
[Risk-stratified screening for diabetes in adults: results of the first investigation in Hungary].[成人糖尿病的风险分层筛查:匈牙利首次调查结果]
Orv Hetil. 2010 Apr 25;151(17):691-6. doi: 10.1556/OH.2010.28819.
3
Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.使用糖尿病风险评分对未诊断的糖尿病和糖耐量受损进行机会性筛查:IGLOO(糖耐量受损与长期结局观察)研究
Diabetes Care. 2005 May;28(5):1187-94. doi: 10.2337/diacare.28.5.1187.
4
Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study.FINDRISC 问卷在瑞典初级保健中识别糖耐量受损个体的可行性。一项基于人群的横断面研究。
Diabet Med. 2012 Dec;29(12):1501-5. doi: 10.1111/j.1464-5491.2012.03664.x.
5
Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.在接受高血压和/或血脂异常治疗的初级保健患者中常见未被检测到的糖代谢异常:临床实践中需要一种筛查策略。这是来自欧洲心脏病学会欧洲观察性研究计划 EUROASPIRE IV 登记处的报告。
Cardiovasc Diabetol. 2018 Jan 24;17(1):21. doi: 10.1186/s12933-018-0665-4.
6
Screening for people with abnormal glucose metabolism in the European DE-PLAN project.欧洲DE-PLAN项目中对糖代谢异常人群的筛查。
Diabetes Res Clin Pract. 2015 Jul;109(1):149-56. doi: 10.1016/j.diabres.2015.04.016. Epub 2015 Apr 20.
7
[Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].[城市职业人群中未诊断出的糖尿病的出现情况]
Pol Arch Med Wewn. 2001 Sep;106(3):815-21.
8
Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.在“PREVIEW:新西兰队列研究”中评估芬兰糖尿病风险评分(FINDRISC)作为超重成年人2型糖尿病筛查工具的效果。
Prim Care Diabetes. 2017 Dec;11(6):561-569. doi: 10.1016/j.pcd.2017.07.003. Epub 2017 Aug 8.
9
Australian Diabetes Screening Study: impaired glucose tolerance and non-insulin-dependent diabetes mellitus.澳大利亚糖尿病筛查研究:糖耐量受损与非胰岛素依赖型糖尿病
Metabolism. 1997 Dec;46(12 Suppl 1):35-9. doi: 10.1016/s0026-0495(97)90315-2.
10
[Prevalence of type II diabetes mellitus in population of Krakow].[克拉科夫人群中2型糖尿病的患病率]
Pol Arch Med Wewn. 2001 Sep;106(3):771-9.

引用本文的文献

1
What a SMART Pharmacist Can Discover in Only One Day: A Public Health Initiative Focused on Diabetes in North Macedonia.一位精明的药剂师一天之内能发现什么:一项聚焦于北马其顿糖尿病问题的公共卫生倡议。
Healthcare (Basel). 2025 Aug 25;13(17):2107. doi: 10.3390/healthcare13172107.
2
FINDRISC modified for Cuba as a tool for the detection of prediabetes and undiagnosed diabetes in cuban population.为古巴修改的芬兰糖尿病风险评分(FINDRISC)作为古巴人群中糖尿病前期和未诊断糖尿病检测工具。
Rev Peru Med Exp Salud Publica. 2025 Jan 31;41(4):351-364. doi: 10.17843/rpmesp.2024.414.14138.
3
Cost-effectiveness of prevention program for type 2 diabetes mellitus in high risk patients in the Republic of Srpska, Bosnia and Herzegovina.

本文引用的文献

1
Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes.评估芬兰糖尿病风险评分作为筛查工具用于检测空腹血糖受损、葡萄糖耐量受损和未检出的糖尿病。
Diabetes Res Clin Pract. 2011 Apr;92(1):46-52. doi: 10.1016/j.diabres.2010.12.020. Epub 2011 Jan 15.
2
The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes.2 型糖尿病和糖耐量受损(DETECT-2)筛查和早期检测策略的评估:芬兰糖尿病风险评分对 2 型糖尿病发病预测的更新。
Diabetologia. 2011 May;54(5):1004-12. doi: 10.1007/s00125-010-1990-7. Epub 2010 Dec 12.
3
波斯尼亚和黑塞哥维那斯普斯卡共和国2型糖尿病高危患者预防项目的成本效益
Libyan J Med. 2025 Dec;20(1):2437226. doi: 10.1080/19932820.2024.2437226. Epub 2024 Dec 15.
4
Identifying Adult Population at Risk for Undiagnosed Diabetes Mellitus in Medan City, Indonesia Targeted on Diabetes Prevention.在印度尼西亚棉兰市确定未诊断糖尿病的成年高危人群以预防糖尿病为目标。
Med Arch. 2023;77(6):455-459. doi: 10.5455/medarh.2023.77.455-459.
5
An Assessment of the 10-Year Risk of Developing Type 2 Diabetes Among Saudi Adults Based on the Finnish Diabetes Risk Score.基于芬兰糖尿病风险评分对沙特成年人患2型糖尿病10年风险的评估。
Cureus. 2022 Nov 29;14(11):e32034. doi: 10.7759/cureus.32034. eCollection 2022 Nov.
6
Risk-based diabetes screening in a Hungarian general practice: comparison of laboratory methods and diagnostic criteria.基于风险的糖尿病筛查在匈牙利常规医疗实践中的应用:实验室方法和诊断标准的比较。
Prim Health Care Res Dev. 2021 Apr 22;22:e17. doi: 10.1017/S1463423621000037.
7
Translation, cross-cultural adaptation and validation of the Finnish Diabetes Risk Score (FINDRISC) for use in Brazilian Portuguese: questionnaire validity study.用于巴西葡萄牙语的芬兰糖尿病风险评分(FINDRISC)的翻译、跨文化调适与验证:问卷效度研究
Sao Paulo Med J. 2020 Jun;138(3):244-252. doi: 10.1590/1516-3180.2019.0524.05032020. Epub 2020 Jun 15.
8
Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study.FINDRISC 在当代挪威人群中预测糖尿病的有效性:HUNT 研究的 10 年随访。
BMJ Open Diabetes Res Care. 2019 Nov 28;7(1):e000769. doi: 10.1136/bmjdrc-2019-000769. eCollection 2019.
9
Impact of sex and age on the performance of FINDRISC: the HUNT Study in Norway.性别和年龄对 FINDRISC 表现的影响:挪威 HUNT 研究。
BMJ Open Diabetes Res Care. 2016 Jun 22;4(1):e000217. doi: 10.1136/bmjdrc-2016-000217. eCollection 2016.
10
Reporting and handling of missing data in predictive research for prevalent undiagnosed type 2 diabetes mellitus: a systematic review.普遍未诊断的2型糖尿病预测性研究中缺失数据的报告与处理:一项系统评价
EPMA J. 2015 Mar 11;6(1):7. doi: 10.1186/s13167-015-0028-0. eCollection 2015.
Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.验证芬兰糖尿病风险评分(FINDRISC)问卷在希腊用于筛查未诊断的 2 型糖尿病、糖调节受损和代谢综合征的适用性。
Diabetes Metab. 2011 Apr;37(2):144-51. doi: 10.1016/j.diabet.2010.09.006. Epub 2010 Dec 7.
4
Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D).初级卫生保健中生活方式干预预防 2 型糖尿病:芬兰国家糖尿病预防计划(FIN-D2D)的一年随访结果。
Diabetes Care. 2010 Oct;33(10):2146-51. doi: 10.2337/dc10-0410. Epub 2010 Jul 27.
5
Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men.芬兰糖尿病风险评分及生化遗传标志物识别未诊断 2 型糖尿病个体:一项基于人群的 7232 例芬兰男性研究
J Clin Endocrinol Metab. 2010 Aug;95(8):3858-62. doi: 10.1210/jc.2010-0012. Epub 2010 May 12.
6
Prevalence rate of diabetes mellitus and impaired fasting glycemia in Hungary: cross-sectional study on nationally representative sample of people aged 20-69 years.匈牙利糖尿病和空腹血糖受损的患病率:对20-69岁具有全国代表性人群样本的横断面研究。
Croat Med J. 2010 Apr;51(2):151-6. doi: 10.3325/cmj.2010.51.151.
7
A European evidence-based guideline for the prevention of type 2 diabetes.欧洲 2 型糖尿病预防循证指南
Horm Metab Res. 2010 Apr;42 Suppl 1:S3-36. doi: 10.1055/s-0029-1240928. Epub 2010 Apr 13.
8
The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes.芬兰糖尿病风险评分与胰岛素抵抗及向2型糖尿病的进展相关。
J Clin Endocrinol Metab. 2009 Mar;94(3):920-6. doi: 10.1210/jc.2007-2427. Epub 2008 Dec 23.
9
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.强化血糖控制与心血管事件预防:ACCORD、ADVANCE及退伍军人糖尿病试验的启示:美国糖尿病协会立场声明及美国心脏病学会基金会与美国心脏协会科学声明
Diabetes Care. 2009 Jan;32(1):187-92. doi: 10.2337/dc08-9026. Epub 2008 Dec 17.
10
Tools for predicting the risk of type 2 diabetes in daily practice.日常实践中预测2型糖尿病风险的工具。
Horm Metab Res. 2009 Feb;41(2):86-97. doi: 10.1055/s-0028-1087203. Epub 2008 Nov 19.